The cost of Dovato (dolutegravir/lamivudine) varies depending on insurance coverage, pharmacy, and whether a prescription assistance program is utilized. Without insurance, the retail price for a 30-day supply can range from approximately $2,200 to $2,700 [1].
What affects the price of Dovato?
The price of Dovato is influenced by several factors. Insurance plans often have co-pays that are significantly lower than the retail price. Manufacturer-sponsored patient assistance programs can also reduce out-of-pocket costs for eligible individuals [1].
Are there ways to get Dovato for less?
Patients may find ways to reduce the cost of Dovato. Prescription discount cards and coupons can offer savings. Additionally, comparing prices at different pharmacies can reveal lower costs. For those who qualify, patient assistance programs from the manufacturer are designed to make the medication more affordable [1].
When does the patent for Dovato expire?
The patent protection for Dovato is a key factor in its pricing and the eventual availability of generic alternatives. According to DrugPatentWatch.com, the patent expiration dates for Dovato are important for understanding future market dynamics [2]. Specific patent expiry dates can be found on specialized patent tracking websites like DrugPatentWatch.com [2].
Can generic versions of Dovato be made?
Once patents expire, generic versions of Dovato can be developed and manufactured. This typically leads to a significant decrease in the cost of the medication due to increased competition. The timeline for generic entry depends on the specific patents held for Dovato and any related formulations or uses [2].
Who makes Dovato?
Dovato is manufactured by ViiV Healthcare [1].
What is Dovato used for?
Dovato is a complete, single-tablet regimen used to treat HIV-1 infection in adults and children who weigh at least 25 kilograms (55 pounds). It is a combination of two antiretroviral medications: dolutegravir, an integrase inhibitor, and lamivudine, a nucleoside analog reverse transcriptase inhibitor [1].
How does Dovato work?
Dovato works by preventing the human immunodeficiency virus (HIV) from multiplying. Dolutegravir inhibits an enzyme called integrase, which HIV needs to insert its genetic material into the host cell's DNA. Lamivudine works by interfering with the virus's ability to make copies of its genetic material [1].
What are the side effects of Dovato?
Common side effects of Dovato can include nausea, diarrhea, headache, fatigue, and insomnia. Serious side effects, though less common, may include liver problems, hypersensitivity reactions, and depression. Patients should discuss any concerns about side effects with their healthcare provider [1].
Sources:
1. https://www.drugs.com/price-guide/dovato
2. https://www.drugpatentwatch.com/